Breaking News Bar

Business News and Information

Recent Quotes
My Watchlist
Indicators
Local Stocks
The Daily Herald Market Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Edge Therapeut Cm S (NQ: EDGE )

0.5036 USD UNCHANGED
Last Price Updated: 8:55 PM EDT, Mar 15, 2019 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Edge Therapeut Cm S

< Previous 1 2 3 Next >
New Stimulus Effort Could Be Boon for Clean Energy ETF ACES
Already one of 2020’s best-performing exchange traded funds, the ALPS Clean Energy ETF (ACES) could be stimulated by the new COVID-19 relief package recently passed by Congress. ACES follows the CIBC... 
Tags BWXT FAN SPWR
From ETF Trends
Houston Mechatronics Adopts Numurus’ NEPI Smart IoT Platform
Tags smart sensors inspection robotics
From PRUnderground
Numurus Joins the 5G Open Innovation Lab
Tags edge cloud AI
From PRUnderground
DIARY - Italy to June 30
Inclusion of diary items does not necessarily mean that Reuters will file a story based on the event. 
Tags companyNews
From Reuters: Company News
DARPA Selects Numurus’ Smart IoT Ecosystem for Ocean Monitoring Program
Tags Information Technology cloud edge
From PRUnderground
The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting ... 
Tags ANIP AKBA SRRA
From Benzinga
The Daily Biotech Pulse: Tilray Inks Cannabis Drink Pact, Double Delight For Merck, FDA Snub For Spectrum
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting ... 
Tags ECYT CELG TARO
From Benzinga
The Daily Biotech Pulse: Pfizer-Glaxo Set Up Consumer Health Care Venture, New Patent For Adamas
Here's a roundup of top developments in the biotech space over the last 24 hours. No biotech stocks hit 52-week highs ... 
Tags VRCA ENZ INSY
From Benzinga
The Daily Biotech Pulse: Puma Aces Late-Stage Trial, Chinese Cheer For FibroGen, J&J $5B Buyback Plan
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting ... 
Tags ONCY TRIB ADMA
From Benzinga
The Daily Biotech Pulse: Management Change At Merck, Jazz Buyback, Arrowhead Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting ... 
Tags NTRP PTX Top Stories
From Benzinga
The Daily Biotech Pulse: FDA Nod For Roche, Bristol-Myers Hikes Dividend, 2 Biotechs To Debut
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting ... 
Tags News Benzinga Top Stories
From Benzinga
The Daily Biotech Pulse: IntelliPharmaCeutics Generic Antidepressant Gets FDA Nod, GW Pharma Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. None of the biotech stocks hit 52-week highs ... 
Tags VRCA TNX GWPH
From Benzinga
Edge Therapeutics, Privately Held PDS Biotech Announce Reverse Merger
Penny stock Edge Therapeutics Inc (NASDAQ: EDGE) is seeing strong buying interest Monday following the announcement of a merger ... 
Tags News Benzinga M&A
From Benzinga
The Daily Biotech Pulse: Mallinckrodt Faces FDA Panel, Reshape's Earnings, Vapotherm To Debut
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting ... 
Tags ALDX TTNP IMMY
From Benzinga
The Daily Biotech Pulse: Johnson & Johnson's Generic Unit Files NDA For Urinary Tract Cancer Drug, G1 Therapeutics Prices Offering
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that ... 
Tags ASNS GTHX PRNB
From Benzinga
The Daily Biotech Pulse: Morphosys Expands Collaboration, Osiris Announces Product Launch, Argenx To Offer Shares
The following are top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week ... 
Tags Benzinga NVCN VCNX
From Benzinga
The Daily Biotech Pulse: FDA Nod For STAAR, Supernus Opens Wallet, Principia Biopharma To Debut
A roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit52-week ... 
Tags EDGE GLPG HSGX
From Benzinga
A Look At Biotech In 2018 And The Biggest Catalysts Coming Up In The Second Half Of The Year
Biotech stocks carved out modest gains in the first half of 2018 and outperformed the broader market, although their gains paled before ... 
Tags ABBV SIGA EDGE
From Benzinga
Benzinga's Daily Biotech Pulse: Eli Lilly, Edge Therapeutics, BioXcel Report Positive Trial Results, 4 Stocks Debut
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week ... 
Tags Earnings IPOs BTAI
From Benzinga
Benzinga's Daily Biotech Pulse: Eiger And Melinta Fall On Offerings, Apellis And Marinus Rise On Bullish Ratings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week ... 
Tags Biotech EIGR CYTX
From Benzinga
Benzinga's Daily Biotech Pulse: Melinta, Ardelyx Pull Back On Offerings, Insys Awaits FDA Verdict
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech Stocks Hitting ... 
Tags MLNT EDGE TTOO
From Benzinga
BRIEF-Edge Therapeutics Reports Quarterly Loss Per Share $0.67
* EDGE THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS 
Tags companyNews
From Reuters: Company News
Benzinga Pro's 6 Stocks To Watch Today
Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a ... 
Tags EDGE FDC TMUS
From Benzinga
41 Biggest Movers From Thursday
Gainers NTN Buzztime Inc (NYSE: NTN) shares climbed 30.48 percent to close at $6.85. Galectin Therapeutics, Inc. ... 
Tags NETS AKCA IQ
From Benzinga
The Week Ahead In Biotech: PDUFA Dates, Clinical Trials And Conferences
Biotech stocks continued to be in the red this week, with the losses worse than what the broader market suffered. Here's a list of ... 
Tags CLVS Benzinga THERF
From Benzinga
36 Stocks Moving In Thursday's Mid-Day Session
Gainers Galectin Therapeutics, Inc. (NASDAQ: GALT) shares surged 20.6 percent to $4.56. Galectin Therapeutics posted a FY17 ... 
Tags NETS IIPR SHSP
From Benzinga
Credit Suisse Slashes Edge Therapeutics Price Target By 94%, Downgrades Stock After Failed Trial
Edge Therapeutics Inc (NASDAQ: EDGE) closed down 87 percent Wednesday and continued to decline Thursday after announcing layoffs, the ... 
Tags EDGE Biotech Credit Suisse
From Benzinga
Benzinga's Top Analyst Calls From March 29, 2018
These headlines first appeared on Benzinga Pro. Wedbush lowers GameStop Corp (NYSE: GME)’s price target from $22.50 to ... 
Tags Price Target TSLA Analyst Color
From Benzinga
First Week of May 18th Options Trading For Edge Therapeutics (EDGE)
Investors in Edge Therapeutics Inc (EDGE) saw new options begin trading this week, for the May 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the EDGE options... 
Tags Stocks
From Market News Video
Benzinga's Top Upgrades, Downgrades For March 29, 2018
Top Upgrades Citigroup upgraded Yandex N.V. (NASDAQ: YNDX) from Neutral to Buy. Yandex shares rose 1.89 percent to $39.99 in ... 
Tags Initiation GME DUK
From Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear
Search DailyHerald.com for articles
More ways to search Daily Herald
Obituaries
Search DailyHerald.com obituaries. » Daily Herald newspaper archive
Find archived newspaper articles back to 1901. »
Digital Subscriptions
Activate Subscriber Access Purchase a Digital Subscription
Home Delivery
Start a New Subscription Manage Account